Kozak W M, Marker N A, Elmer K K
Biomedical Engineering Program, Carnegie-Mellon University, Pittsburgh, PA 15213.
Doc Ophthalmol. 1986;64(4):355-77. doi: 10.1007/BF00212059.
Experiments were performed on Streptozotocin-diabetic rats to investigate the preventive effect of an aldose reductase inhibitor, Sorbinil, on the deterioration of electroretinograms and retinal tissue that normally occurs during diabetes, and to determine Sorbinil's effect on the general health indices: food and water intake, urine glucose and ketones, body weight, and blood glucose levels in diabetic rats. Two dosages of Sorbinil were tested, 60 mg/kg/24 hours and 10 mg/kg/24 hours. Electroretinograms and the above health indices were measured before injection of Streptozotocin and again after a three week period of diabetes. Sample eyes were then examined by electron microscope and the thickness of the retinal capillary basement membranes was measured. Statistical evaluation showed that Sorbinil-treated diabetic rats did not experience the same lengthening of latencies and reduction in amplitude of various electroretinogram components that occurred in non-treated diabetic rats. Sorbinil improved the general health of diabetic rats and reduced their mortality rates as well. Preliminary electron microscope studies showed a correlation between thickness of the retinal capillary basement membrane and various electroretinogram parameters.
对链脲佐菌素诱导的糖尿病大鼠进行实验,以研究醛糖还原酶抑制剂索比尼尔对糖尿病期间通常发生的视网膜电图和视网膜组织恶化的预防作用,并确定索比尼尔对一般健康指标的影响:糖尿病大鼠的食物和水摄入量、尿糖和酮体、体重以及血糖水平。测试了两种剂量的索比尼尔,即60毫克/千克/24小时和10毫克/千克/24小时。在注射链脲佐菌素之前以及糖尿病三周后再次测量视网膜电图和上述健康指标。然后通过电子显微镜检查样本眼睛,并测量视网膜毛细血管基底膜的厚度。统计评估表明,接受索比尼尔治疗的糖尿病大鼠并未出现未治疗的糖尿病大鼠中发生的各种视网膜电图成分潜伏期延长和振幅降低的情况。索比尼尔改善了糖尿病大鼠的总体健康状况,并降低了它们的死亡率。初步的电子显微镜研究表明,视网膜毛细血管基底膜的厚度与各种视网膜电图参数之间存在相关性。